Search for: "Actavis Pharma"
Results 221 - 240
of 243
Sorted by Relevance
|
Sort by Date
27 Nov 2018, 3:19 am
| Special interview with Mariana Karepova, the President of the Austrian Patent Office | ChIPs Global Summit Report 1: Politics and Technology - When D.C. met Silicon Valley | Book review: Kritika - Essays on Intellectual Property (vol 3) | Tuesday TiddlywinksNever Too Late 202 [Week ending 7 October] Looking to discuss the latest developments in competition law in the pharma sector? [read post]
5 Jul 2008, 11:05 am
: (Spicy IP), Aspen pays £170M for IP rights to Eltroxin, Imuran, Lanoxin and Zyloric: (Afro-IP), Year after settling global patent feud over smallpox vaccine, Barvarian Nordic sues Oxford BioMedica over patents related to same virus: (IP Law360), Australia: Age reports former GSK executive’s victory in court action brought by GSK alleging he started a competing business using GSK’s confidential information: (IPwar’s), Brazil: ANVISA to review Brazilian… [read post]
6 Jun 2017, 1:00 am
The District Court first considered relevant decisions from the German courts (LG Hamburg 2 April 2015, Warner-Lambert v A Pharma; OLG Düsseldorf 1 December 2015, KKH v Pfizer), and UK court (England and Wales Court of Appeal 28 May 2015 and 13 October 2016, Warner-Lambert v Actavis). [read post]
22 Mar 2016, 4:00 am
Although manufacturers are still fragmented, consolidations continue based on “better rationales” (given the standard merger rewards may not necessarily exist): including Pfizer/Hospira, Teva/Actavis and focused start-ups. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
28 Mar 2014, 5:33 pm
.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
26 Oct 2020, 2:49 am
Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly’s patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed by the marketing of Fresenius’ pemetrexed diacid. [read post]
26 May 2019, 2:13 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
13 Jun 2019, 1:06 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
16 Jun 2019, 11:07 am
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
24 May 2019, 8:38 am
A full breakdown of the event's discussions can be found here.AmeriKat Annsley Merelle Ward has compiled a compendium of all the Fordham IP conference blog posts here.Eleonora Rosati reminds readers of two upcoming events - the European Pharma Law Academy which is returning to Cambridge this September, and the joint IPKat and BLACA (the British Literary and Artistic Copyright Association) event on 'The EU DSM Directive: End of the Story? [read post]
3 Aug 2015, 5:10 am
Pick one of those and it will surely work (albeit it would be a mere arbitrary, non-inventive selection of the type discussed in Actavis v Novartis [2010]). [read post]
2 Apr 2013, 10:33 am
Actavis (12-416). [read post]
20 Jun 2018, 4:12 am
On 3 January 2017 Mepha Pharma AG, a Swiss subsidiary of Teva, filed a revocation action against Gilead’s Swiss SPC. [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
16 Nov 2007, 4:00 am
., have called a truce in their worldwide patent war over GPS systems, settling all their litigation in the United States, United Kingdom and the Netherlands: (IPLaw360),AT&T's plan to placate Hollywood by adding antipiracy technology to its network: (IPLawDaily), Ocean Tomo announces results of auction held in late October: (PatentDocs), Technology Patents LLC has filed a lawsuit against 131 companies worldwide alleging infringement of patents relating to text messaging: (arstechnica),… [read post]
6 May 2010, 9:43 am
For instance, in the context of prescription pharma, much of the information relied upon by health care professionals comes from the Physicians Desk Reference (“PDR”). [read post]
21 Jul 2022, 8:20 am
Hacon HHJ referred to his earlier decision in Kwikbolt Limited v Airbus Operations Limited [2021] EWHC 732 (IPEC), where he suggested that focussing on the variant by reference to the integers of the claim can be a useful way of considering an alleged equivalent: “[99] The doctrine of equivalents as explained in Actavis requires the variant to be specified. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
23 May 2008, 1:03 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 16 June / 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ -… [read post]
